Similar companies
Did Galectin Therapeutics Beat Earnings?
Galectin Therapeutics (GALT) reported Q2 '26 revenue of $0.
AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Galectin Therapeutics’s job postings, web traffic, and employee business outlook. See the full GALT stock analysis or the earnings calendar for upcoming reports.
Galectin Therapeutics Quarterly Financial Trends
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | 36,000 | — | — | — | — | — | — |
| Gross margin | — | -27.8% | — | — | — | — | — | — |
| Operating margin | — | -34,522.2% | — | — | — | — | — | — |
| Net income | -11M | -12M | -9.6M | -7.5M | -8.2M | -5.5M | -5M | -9.1M |
| Net margin | — | -33,241.7% | — | — | — | — | — | — |
| EPS | — | — | — | — | — | — | — | — |
Galectin Therapeutics Earnings Trend Analysis
Over the eight quarters from Q3 '24 to Q2 '26, Galectin Therapeutics’s quarterly revenue moved from $0 to $0.
When Is Galectin Therapeutics’s Next Earnings Date?
Galectin Therapeutics reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the GALT earnings calendar.
Frequently Asked Questions: Galectin Therapeutics Earnings
Galectin Therapeutics's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.
Galectin Therapeutics reported Q2 '26 revenue of $0.
Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the GALT AI Score.
